That is the title of the podcast episode I was on for AJMC’s Managed Care Cast. We discuss my recently published paper on insurance value in Duchenne’s Muscular Dystrophy (DMD). To learn more about research in DMD, check out AJMC’s DMD compendia page. The full podcast is below.
Similar Posts
EMA Committee’s Negative Opinion for Eisai Alzheimer’s Drug Focuses on Safety Risks – MedCity News
Eisai’s efforts to bring its FDA-approved Alzheimer’s disease drug to patients in Europe have hit a…
Thyme Care Raises $95M To Advance Cancer Care – MedCity News
Thyme Care, a value-based cancer care company, has secured $95 million in Series C funding, which…
This Ingredient Boosts Immunity (Even In Small Amounts)
The word “superfood” is often overused, but if there ever was a list of truly super…
Acai Berry Diet – Aids In Weight Loss And Anti Aging
Spread the love The Acai Berry is taking the world by storm. Just the mention of…
The BIOSECURE Act: Q&A – Healthcare Economist
What is it? The BIOSECURE Act is a bill seeks to stop firms that receive federal…
Dairy-Free Cheesecake with a Secret Ingredient
Taking charge of your diet and eating habits is no easy task. When you make the…
